Akanda Corp.
AKAN | NASDAQ
$3.17
+$0.11 (+3.59%)
Sep 22, 2026, 2:46 PM ET · Market open
Company Profile
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer & Executive Director |
| Gurcharn Deol | Chief Financial Officer |
| Edgar Contreras | Country Manager of First Towers |
| Francisco Juarez | VP, COO & Director of First Towers |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 04, 2026 | 6-K | Filing |
| Aug 17, 2026 | 6-K | Filing |
| Aug 13, 2026 | 6-K | Filing |
| Jun 18, 2026 | 6-K | Filing |
| Jun 12, 2026 | 6-K | Filing |
| Jun 09, 2026 | 20-F | Filing |
| May 22, 2026 | 6-K | Filing |
| May 13, 2026 | 6-K | Filing |
| May 01, 2026 | NT 20-F | Filing |
| Apr 29, 2026 | 6-K | Filing |
Akanda Corp.
| Country | Canada |
| IPO Date | Mar 14, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Katharyn Field |
Contact Details
100 King St. W Toronto,
ON M5X 1G5 Canada
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M700 |
| ISIN Number | CA00971M7008 |
| SIC Code | 2833 |
Add to Watchlist
Select watchlists to add or remove AKAN